AC Immune (ACIU) Revenue (2017 - 2025)
AC Immune (ACIU) has disclosed Revenue for 1 consecutive years, with $14.2 million as the latest value for Q4 2017.
- On a quarterly basis, Revenue changed N/A to $14.2 million in Q4 2017 year-over-year; TTM through Dec 2020 was $14.2 million, a 0.0% change, with the full-year FY2024 number at $31.2 million, up 89.17% from a year prior.
- Revenue was $14.2 million for Q4 2017 at AC Immune.
- In the past five years, Revenue ranged from a high of $14.2 million in Q4 2017 to a low of $14.2 million in Q4 2017.